Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/a-comprehensive-guide-to-core-needle-biopsies-of-the-breast-Do4Ch3XnhB
References (105)
-
N. Bijker, P. Meijnen, J. Peterse, J. Bogaerts, I. Hoorebeeck, J. Julien, M. Gennaro, P. Rouanet, A. Avril, I. Fentiman, H. Bartelink, E. Rutgers (2006)
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 21
-
G. Ho, Jacqueline Calvano, Maria Bisogna, P. Borgen, P. Rosen, L. Tan, K. Zee (2000)
In microdissected ductal carcinoma in situ, HER‐2/neu amplification, but not p53 mutation, is associated with high nuclear grade and comedo histologyCancer, 89
-
L. Esserman, I. Thompson, B. Reid, P. Nelson, D. Ransohoff, H. Welch, S. Hwang, D. Berry, K. Kinzler, W. Black, M. Bissell, H. Parnes, S. Srivastava (2014)
Addressing overdiagnosis and overtreatment in cancer: a prescription for change.The Lancet. Oncology, 15 6
-
V. Sacchini, L. Fortunato, H. III, K. Zee, B. Cutuli, B. Bonanni (2012)
Breast Ductal Carcinoma In SituInternational Journal of Surgical Oncology, 2012
-
D. Dabbs, M. Chivukula, G. Carter, R. Bhargava (2006)
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profileModern Pathology, 19
-
D. Page, W. Dupont, L. Rogers, R. Jensen, P. Schuyler (1995)
Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsyCancer, 76
-
D. Page, W. Dupont, L. Rogers, Margaret Rados (1985)
Atypical hyperplastic lesions of the female breast. A long‐term follow‐up studyCancer, 55
-
L. Hartmann, A. Degnim, R. Santen, W. Dupont, K. Ghosh (2015)
Atypical hyperplasia of the breast--risk assessment and management options.The New England journal of medicine, 372 1
-
D. Page, W. Dupont (1992)
Benign breast disease: indicators of increased breast cancer risk.Cancer detection and prevention, 16 2
-
R. Sørum, S. Hofvind, P. Skaane, T. Haldorsen (2010)
Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme.Breast, 19 6
-
C. Riedl, N. Luft, Clemens Bernhart, Michael Weber, M. Bernathova, M. Tea, M. Rudas, C. Singer, T. Helbich (2015)
Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 10
-
T. Brown, Joseph Wall, E. Christensen, Donald Smith, Charlene Holt, P. Carter, T. Patience, Sankaran Babu, William Williard (1998)
Atypical hyperplasia in the era of stereotactic core needle biopsyJournal of Surgical Oncology, 67
-
R. Jackman, R. Birdwell, D. Ikeda (2002)
Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?Radiology, 224 2
-
G. Sue, A. Chagpar (2015)
Predictors of Recurrence in Patients Diagnosed with Ductal Carcinoma In SituThe American Surgeon, 81
-
Bradley Bryan, S. Schnitt, L. Collins (2006)
Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancerModern Pathology, 19
-
L. Philpotts, Carol Lee, L. Horvath, R. Lange, D. Carter, I. Tocino (2000)
Underestimation of breast cancer with II-gauge vacuum suction biopsy.AJR. American journal of roentgenology, 175 4
-
Yuxia Gao, Y. Niu, Xiaowei Wang, Li Wei, Song Lu (2009)
Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridizationJournal of Molecular Medicine, 87
-
M. Sanders, P. Schuyler, W. Dupont, D. Page (2005)
The natural history of low‐grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long‐term follow‐upCancer, 103
-
R. Jackman, K. Nowels, M. Shepard, S. Finkelstein, F. Marzoni (1994)
Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia.Radiology, 193 1
-
T. Tot (2015)
Early (<10 mm) HER2-Positive Invasive Breast Carcinomas are Associated with Extensive Diffuse High-Grade DCIS: Implications for Preoperative Mapping, Extent of Surgical Intervention, and Disease-Free SurvivalAnnals of Surgical Oncology, 22
-
R. Natrajan, M. Lambros, F. Geyer, C. Marchiò, D. Tan, R. Vatcheva, K. Shiu, D. Hungermann, S. Rodríguez-Pinilla, J. Palacios, A. Ashworth, H. Buerger, J. Reis-Filho (2009)
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?Genes, 48
-
M. Silverstein, M. Lagios, P. Craig, J. Waisman, B. Lewinsky, W. Colburn, D. Poller (1996)
A prognostic index for ductal carcinoma in situ of the breastCancer, 77
-
Ana Lourenco, M. Mainiero, E. Lazarus, D. Giri, B. Schepps (2007)
Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy.AJR. American journal of roentgenology, 189 5
-
L. Liberman, Misha Cohen, D. Dershaw, A. Abramson, L. Hann, P. Rosen (1995)
Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy.AJR. American journal of roentgenology, 164 5
-
B. Virnig, T. Tuttle, T. Shamliyan, R. Kane (2010)
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.Journal of the National Cancer Institute, 102 3
-
W. Berg, T. Krebs, C. Campassi, L. Magder, C. Sun (1997)
Evaluation of 14- and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model.Radiology, 205 1
-
K. Allison, L. Reisch, P. Carney, D. Weaver, S. Schnitt, F. O'Malley, B. Geller, J. Elmore (2014)
Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panelHistopathology, 65
-
J. Reis-Filho, P. Simpson, Theodora Gale, S. Lakhani (2005)
The molecular genetics of breast cancer: the contribution of comparative genomic hybridization.Pathology, research and practice, 201 11
-
K. Kerlikowske (2010)
Epidemiology of ductal carcinoma in situ.Journal of the National Cancer Institute. Monographs, 2010 41
-
T. Abdel-Fatah, D. Powe, Z. Hodi, Andrew Lee, J. Reis-Filho, I. Ellis (2007)
High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular CarcinomaThe American Journal of Surgical Pathology, 31
-
N. Houssami, S. Ciatto, I. Ellis, D. Ambrogetti (2007)
Underestimation of malignancy of breast core‐needle biopsyCancer, 109
-
J. Elmore, G. Longton, P. Carney, B. Geller, T. Onega, A. Tosteson, H. Nelson, M. Pepe, K. Allison, S. Schnitt, F. O'Malley, D. Weaver (2015)
Diagnostic concordance among pathologists interpreting breast biopsy specimens.JAMA, 313 11
-
C. Kuhl, S. Schrading, H. Bieling, E. Wardelmann, C. Leutner, R. Koenig, W. Kuhn, H. Schild (2007)
MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational studyThe Lancet, 370
-
B. Shoker, C. Jarvis, R. Clarke, E. Anderson, Joanne Hewlett, M. Davies, D. Sibson, J. Sloane (1999)
Estrogen receptor-positive proliferating cells in the normal and precancerous breast.The American journal of pathology, 155 6
-
PS Larson, A. Morenas, S. Cerda, SR Bennett, L. Cupples, CL Rosenberg (2006)
Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursorsThe Journal of Pathology, 209
-
S. Lester (2010)
Protocol for the Examination of Specimens from Patients with Ductal Carcinoma In Situ ( DCIS ) of the Breast Protocol applies to DCIS without invasive carcinoma or microinvasion -
Y. Sagara, M. Mallory, S. Wong, F. Aydoğan, S. Desantis, W. Barry, M. Golshan (2015)
Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.JAMA surgery, 150 8
-
D. Page, W. Dupont, L. Rogers, M. Landenberger (1982)
Intraductal carcinoma of the breast: Follow‐up after biopsy onlyCancer, 49
-
W. Boecker, H. Buerger, Klaus Schmitz, Ian Ellis, P. Diest, H. Sinn, J. Geradts, R. Diallo, C. Poremba, Hermann Herbst (2001)
Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high‐molecular‐weight cytokeratin expression patternsThe Journal of Pathology, 195
-
M. Stratton, N. Collins, S. Lakhani, J. Sloane (1995)
Loss of heterozygosity in ductal carcinoma in situ of the breastThe Journal of Pathology, 175
-
L. Collins, R. Tamimi, H. Baer, J. Connolly, G. Colditz, S. Schnitt (2005)
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsyCancer, 103
-
Shi-Yi Wang, T. Shamliyan, B. Virnig, R. Kane (2011)
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysisBreast Cancer Research and Treatment, 127
-
M. Nguyen, M. McCombs, S. Ghandehari, A. Kim, Hong Wang, S. Barsky, S. Love, L. Bassett (1996)
An update on core needle biopsy for radiologically detected breast lesionsCancer, 78
-
S. Lakhani, N. Collins, Michael Stratton, J. Sloane (1995)
Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.Journal of Clinical Pathology, 48
-
M. López-García, F. Geyer, M. Lacroix-Triki, C. Marchiò, J. Reis-Filho (2010)
Breast cancer precursors revisited: molecular features and progression pathwaysHistopathology, 57
-
W. Betsill, P. Rosen, P. Lieberman, G. Robbins (1978)
Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone.JAMA, 239 18
-
Alizée Caplain, Y. Drouet, M. Peyron, M. Peix, C. Faure, C. Chassagne‐Clément, F. Beurrier, Marie-Eve Fondrevelle, N. Guérin, C. Lasset, I. Treilleux (2014)
Management of patients diagnosed with atypical ductal hyperplasia by vacuum-assisted core biopsy: a prospective assessment of the guidelines used at our institution.American journal of surgery, 208 2
-
F. Burbank (1997)
Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy.Radiology, 202 3
-
H. Welch, W. Black (2010)
Overdiagnosis in cancer.Journal of the National Cancer Institute, 102 9
-
E. Fisher, J. Dignam, E. Tan-chiu, J. Costantino, B. Fisher, S. Paik, N. Wolmark (1999)
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17Cancer, 86
-
C. Lehman (2010)
Magnetic resonance imaging in the evaluation of ductal carcinoma in situ.Journal of the National Cancer Institute. Monographs, 2010 41
-
J. Meyer, Darrell Smith, S. Lester, C. Kaelin, P. DiPiro, C. Denison, R. Christian, S. Harvey, Donna‐Lee Selland, S. Durfee (1999)
Large-core needle biopsy of nonpalpable breast lesions.JAMA, 281 17
-
L. Hughes, Molin Wang, D. Page, R. Gray, L. Solin, N. Davidson, M. Lowen, J. Ingle, A. Recht, W. Wood (2009)
Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 32
-
P. Sęk, A. Żawrocki, W. Biernat, J. Piekarski (2010)
HER2 molecular subtype is a dominant subtype of mammary Paget’s cells. An immunohistochemical studyHistopathology, 57
-
M. Moore, C. Hargett, J. Hanks, L. Fajardo, J. Harvey, H. Frierson, C. Slingluff (1997)
Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy.Annals of surgery, 225 6
-
W. Gradishar, B. Anderson, R. Balassanian, S. Blair, H. Burstein, Amy Cyr, A. Elias, W. Farrar, A. Forero, S. Giordano, M. Goetz, L. Goldstein, C. Hudis, S. Isakoff, P. Marcom, I. Mayer, B. McCormick, M. Moran, Sameer Patel, L. Pierce, E. Reed, K. Salerno, L. Schwartzberg, K. Smith, Mary Smith, H. Soliman, G. Somlo, M. Telli, J. Ward, Dorothy Shead, Rashmi Kumar (2015)
Breast cancer version 2.2015: Clinical practice guidelines in oncologyJournal of The National Comprehensive Cancer Network, 13
-
E. Doren, M. Hulvat, J. Norton, P. Rajan, S. Sarker, G. Aranha, K. Yao (2008)
Predicting cancer on excision of atypical ductal hyperplasia.American journal of surgery, 195 3
-
L. Liberman, D. Dershaw, J. Glassman, A. Abramson, E. Morris, L. LaTrenta, P. Rosen (1997)
Analysis of cancers not diagnosed at stereotactic core breast biopsy.Radiology, 203 1
-
M. Bur, M. Zimarowski, S. Schnitt, S. Baker, R. Lew (2010)
Estrogen receptor immunohistoohemistry in carcinoma in situ of the breastCancer, 69
-
L. Liberman, J. Kaplan, E. Morris, A. Abramson, J. Menell, D. Dershaw (2002)
To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy?AJR. American journal of roentgenology, 179 3
-
W. Burak, Kerry Owens, Mary Tighe, Lisa Kemp, Susan Dinges, C. Hitchcock, J. Olsen (2000)
Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions.Archives of surgery, 135 6
-
S. Schnitt, J. Connolly, F. Tavassoli, R. Fechner, R. Kempson, R. Gelman, D. Page (1992)
Interobserver Reproducibility in the Diagnosis of Ductal Proliferative Breast Lesions Using Standardized CriteriaThe American Journal of Surgical Pathology, 16
-
A. Shaaban, J. Sloane, C. West, C. Foster (2002)
Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.The American journal of pathology, 160 2
-
I. Tocino, B. García, D. Carter (1996)
Surgical biopsy findings in patients with atypical hyperplasia diagnosed by stereotaxic core needle biopsyAnnals of Surgical Oncology, 3
-
J. Cangiarella, J. Waisman, W. Symmans, Joshua Gross, J. Cohen, Horace Wu, D. Axelrod (2001)
Mammotome core biopsy for mammary microcalcificationCancer, 91
-
P. Fitzgibbons, D. Henson, R. Hutter (1998)
Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.Archives of pathology & laboratory medicine, 122 12
-
E. Gareth, K. Nisha, Lim Yit, Gadde Soujanye, H. Emma, N. Massat, A. Maxwell, Ingham Sarah, Eeles Rosalind, M. Leach, Howell Anthony, Duffy Stephen, Maribs Group (2014)
MRI breast screening in high-risk women: cancer detection and survival analysisBreast Cancer Research and Treatment, 145
-
M. Shekhar, P. Nangia-Makker, S. Wolman, Larry Tait, Gloria Heppner, Daniel Visscher (1998)
Direct action of estrogen on sequence of progression of human preneoplastic breast disease.The American journal of pathology, 152 5
-
L. Solin, R. Gray, F. Baehner, S. Butler, L. Hughes, C. Yoshizawa, D. Cherbavaz, S. Shak, D. Page, G. Sledge, N. Davidson, J. Ingle, E. Perez, W. Wood, J. Sparano, S. Badve (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the BreastJNCI Journal of the National Cancer Institute, 105
-
Daniel Gadzala, G. Cederbom, J. Bolton, W. McKinnon, G. Farr, J. Champaign, Karl Ordoyne, Keith Chung, G. Fuhrman (1997)
Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsyAnnals of Surgical Oncology, 4
-
G. Fuhrman, G. Cederbom, J. Bolton, Tari King, J. Duncan, J. Champaign, D. Smetherman, G. Farr, R. Kuske, W. McKinnon (1998)
Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities.Annals of surgery, 227 6
-
J. Reis-Filho, S. Lakhani (2003)
The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesionsBreast Cancer Research, 5
-
H. Buerger, F. Otterbach, R. Simon, C. Poremba, R. Diallo, T. Decker, L. Riethdorf, C. Brinkschmidt, B. Dockhorn‐Dworniczak, W. Boecker (1999)
Comparative genomic hybridization of ductal carcinoma in situ of the breast—evidence of multiple genetic pathwaysThe Journal of Pathology, 187
-
P. Stomper, F. Margolin (1994)
Ductal carcinoma in situ: the mammographer's perspective.AJR. American journal of roentgenology, 162 3
-
J. Benson, G. Wishart (2013)
Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery.The Lancet. Oncology, 14 9
-
S. Shin, P. Rosen (2000)
Pregnancy-like (Pseudolactational) Hyperplasia: A Primary Diagnosis in Mammographically Detected Lesions of the Breast and Its Relationship to Cystic Hypersecretory HyperplasiaThe American Journal of Surgical Pathology, 24
-
I. Wapnir, J. Dignam, B. Fisher, E. Mamounas, S. Anderson, T. Julian, S. Land, R. Margolese, S. Swain, J. Costantino, N. Wolmark (2011)
Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.Journal of the National Cancer Institute, 103 6
-
M. Vijver, J. Peterse, W. Mooi, Peter Wisman, Job Lomans, O. Dalesio, R. Nusse (1988)
Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer.The New England journal of medicine, 319 19
-
R. Jain, R. Mehta, R. Dimitrov, L. Larsson, P. Musto, K. Hodges, T. Ulbright, E. Hattab, Narasimhan Agaram, Muhammad Idrees, S. Badve (2011)
Atypical ductal hyperplasia: interobserver and intraobserver variabilityModern Pathology, 24
-
L. Hartmann, D. Radisky, M. Frost, R. Santen, R. Vierkant, Lorelle Benetti, Y. Tarabishy, K. Ghosh, D. Visscher, A. Degnim (2014)
Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort StudyCancer Prevention Research, 7
-
Marla Darling, Darrell Smith, S. Lester, C. Kaelin, Donna‐Lee Selland, C. Denison, P. DiPiro, David Rose, E. Rhei, J. Meyer (2000)
Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision.AJR. American journal of roentgenology, 175 5
-
R. Jackman, K. Nowels, J. Rodriguez-Soto, F. Marzoni, Solon Finkelstein, Michael Shepard (1999)
Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.Radiology, 210 3
-
I. Ellis, S. Pinder, A. Lee, C. Elston (1999)
A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?Seminars in diagnostic pathology, 16 3
-
P. Eby, J. Ochsner, Wendy DeMartini, K. Allison, S. Peacock, C. Lehman (2009)
Frequency and upgrade rates of atypical ductal hyperplasia diagnosed at stereotactic vacuum-assisted breast biopsy: 9-versus 11-gauge.AJR. American journal of roentgenology, 192 1
-
Andrew Renshaw, N. Cartagena, Randy Schenkman, R. Derhagopian, E. Gould (2001)
Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies.American journal of clinical pathology, 116 1
-
D. Allred, S. Anderson, S. Paik, D. Wickerham, I. Nagtegaal, S. Swain, E. Mamounas, T. Julian, C. Geyer, J. Costantino, S. Land, N. Wolmark (2012)
Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 12
-
T. Jacobs, J. Connolly, S. Schnitt (2002)
Nonmalignant Lesions in Breast Core Needle Biopsies: To Excise or Not to Excise?The American Journal of Surgical Pathology, 26
-
S. Saverio, F. Catena, D. Santini, L. Ansaloni, T. Fogacci, S. Mignani, A. Leone, F. Gazzotti, S. Gagliardi, A. Cataldis, M. Taffurelli (2008)
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow upBreast Cancer Research and Treatment, 109
-
S. Hofvind, R. Sørum, S. Thoresen (2008)
Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-programActa Oncologica, 47
-
C. Elston, J. Sloane, I. Amendoeira, N. Apostolikas, J. Bellocq, S. Bianchi, W. Boecker, G. Bussolati, D. Coleman, C. Connolly, P. Dervan, M. Drijkoningen, V. Eusebi, D. Faverly, R. Holland, J. Jacquemier, M. Lacerda, J. Martínez-Peñuela, C. Miguel, S. Moss, C. Munt, J. Peterse, F. Rank, Angelika Reiner, M. Sylván, Clive Wells, B. Zafrani (2000)
Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.European journal of cancer, 36 14
-
K. Williams, N. Barnes, A. Cramer, R. Johnson, K. Cheema, J. Morris, M. Howe, N. Bundred (2015)
Molecular phenotypes of DCIS predict overall and invasive recurrence.Annals of oncology : official journal of the European Society for Medical Oncology, 26 5
-
S. Borgquist, Wenjing Zhou, K. Jirström, R. Amini, Thomas Sollie, T. Sørlie, C. Blomqvist, S. Butt, F. Wärnberg (2015)
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort studyBMC Cancer, 15
-
R. Maganini, DavidC Klem, Bernard Huston, Elizabeth Bruner, H.Kurt Jacobs (2001)
Upgrade rate of core biopsy-determined atypical ductal hyperplasia by open excisional biopsy.American journal of surgery, 182 4
-
L. Collins, S. Schnitt (2005)
HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapyModern Pathology, 18
-
P. Lin, J. Clyde, D. Bates, J. García, G. Matsumoto, G. Girvin (1998)
Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia.American journal of surgery, 175 5
-
K. Allison, P. Eby, Jennifer Kohr, Wendy DeMartini, C. Lehman (2011)
Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade.Human pathology, 42 1
-
M. Hammond, Daniel Hayes, M. Dowsett, D. Allred, K. Hagerty, S. Badve, P. Fitzgibbons, G. Francis, Neil Goldstein, M. Hayes, David Hicks, S. Lester, R. Love, P. Mangu, L. McShane, K. Miller, C. Osborne, S. Paik, J. Perlmutter, A. Rhodes, H. Sasano, Jared Schwartz, F. Sweep, S. Taube, E. Torlakovic, P. Valenstein, G. Viale, D. Visscher, T. Wheeler, R. Williams, J. Wittliff, Antonio Wolff (2010)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.Archives of pathology & laboratory medicine, 134 6
-
W. Dupont, D. Page (1985)
Risk factors for breast cancer in women with proliferative breast disease.The New England journal of medicine, 312 3
-
K. Allison, L. Abraham, D. Weaver, A. Tosteson, H. Nelson, T. Onega, B. Geller, K. Kerlikowske, P. Carney, L. Ichikawa, D. Buist, J. Elmore (2015)
Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: A report from the Breast Cancer Surveillance ConsortiumCancer, 121
-
F. Tavassoli, H. Norris (1990)
A comparison of the results of long‐term follow‐up for atypical intraductal hyperplasia and intraductal hyperplasia of the breastCancer, 65
-
P. Simpson, J. Reis-Filho, Theodora Gale, S. Lakhani (2005)
Molecular evolution of breast cancerThe Journal of Pathology, 205
-
Lucía Hernández, P. Wilkerson, M. Lambros, Adriana Campion-Flora, D. Rodrigues, A. Gauthier, Cecilia Cabral, Vidya Pawar, A. Mackay, R. A’Hern, C. Marchiò, J. Palacios, R. Natrajan, B. Weigelt, J. Reis-Filho (2012)
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal selectionThe Journal of Pathology, 227
-
W. Wood, M. Alvarado, D. Buchholz, D. Hyams, S. Hwang, J. Manders, Catherine Park, L. Solin, J. White, S. Willey (2014)
The current clinical value of the DCIS Score.Oncology, 28 Suppl 2
-
V. Ernster, R. Ballard-Barbash, W. Barlow, Yingye Zheng, D. Weaver, G. Cutter, B. Yankaskas, R. Rosenberg, P. Carney, K. Kerlikowske, S. Taplin, N. Urban, B. Geller (2002)
Detection of ductal carcinoma in situ in women undergoing screening mammography.Journal of the National Cancer Institute, 94 20
-
T. Abdel-Fatah, D. Powe, Z. Hodi, J. Reis-Filho, Andrew Lee, I. Ellis (2008)
Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia FamilyThe American Journal of Surgical Pathology, 32
- Publisher
- Springer International Publishing
- Copyright
- © Springer International Publishing Switzerland 2016
- ISBN
- 978-3-319-26289-5
- Pages
- 337 –375
- DOI
- 10.1007/978-3-319-26291-8_9
- Publisher site
- See Chapter on Publisher Site
Abstract
[The diagnostic evaluation of intraductal proliferations, including ductal carcinoma in situ (DCIS), atypical ductal hyperplasia (ADH), and usual ductal hyperplasia (UDH) is one of the most common diagnostic challenges in breast pathology. While proliferations on the ends of this diagnostic spectrum (high-grade DCIS and classic usual ductal hyperplasia) are usually more straightforward to classify, the distinction between low-grade DCIS and ADH can be particularly problematic. An understanding of the biology of these lesions reveals more about their complexity and which lesions are more closely related to each other. When evaluating intraductal proliferations on core needle biopsy samples, pathologists should understand the critical aspects of establishing these diagnoses as well as their clinical impact. This chapter will review practical approaches to the diagnosis of intraductal proliferative lesions on core biopsy as well as some of their diagnostic challenges and clinical implications.]
Published: Sep 17, 2016
Keywords: Intraductal proliferations; Atypical ductal hyperplasia; ADH; Ductal carcinoma in situ; DCIS; Usual ductal hyperplasia; UDH; Diagnostic agreement